Skip to Content

ChromaDex Corp CDXC

Morningstar Rating
$2.61 −0.27 (9.38%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CDXC is trading at a 571% premium.
Price
$2.62
Fair Value
$7.29
Uncertainty
Very High
1-Star Price
$1.92
5-Star Price
$6.63
Economic Moat
Qzjw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CDXC is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$2.88
Day Range
$2.523.08
52-Week Range
$1.254.65
Bid/Ask
$2.54 / $2.78
Market Cap
$197.16 Mil
Volume/Avg
708,914 / 385,546

Key Statistics

Price/Earnings (Normalized)
277.10
Price/Sales
2.36
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.
Sector
Consumer Defensive
Industry
Packaged Foods
Stock Style Box
Small Core
Total Number of Employees
106

Comparables

Valuation

Metric
CDXC
PNT
CRMD
Price/Earnings (Normalized)
277.1011.36
Price/Book Value
6.783.124.53
Price/Sales
2.365.50
Price/Cash Flow
59.1813.90
Price/Earnings
CDXC
PNT
CRMD

Financial Strength

Metric
CDXC
PNT
CRMD
Quick Ratio
1.759.016.14
Current Ratio
2.529.146.65
Interest Coverage
−1,546.89
Quick Ratio
CDXC
PNT
CRMD

Profitability

Metric
CDXC
PNT
CRMD
Return on Assets (Normalized)
1.73%20.67%−62.43%
Return on Equity (Normalized)
3.34%23.56%−71.06%
Return on Invested Capital (Normalized)
0.32%23.38%−74.95%
Return on Assets
CDXC
PNT
CRMD
See how this stock stacks up to its competitors with Morningstar Investor

Packaged Foods Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Nestle SA ADR
NSRGY
KslvnvrdMtbp$276.7 Bil
Danone SA ADR
DANOY
DgmckvgnGkzbdsq$41.3 Bil
The Kraft Heinz Co
KHC
JcbcwzrfYyhnsp$38.9 Bil
General Mills Inc
GIS
KhgsjhtmSktxf$35.2 Bil
Kellanova Co
K
PvtxhcjdjWwpbll$19.3 Bil
McCormick & Co Inc Registered Shs Non Vtg
MKC
ZyftyntdWhm$19.2 Bil
Hormel Foods Corp
HRL
CgxwtbvcjwXwkgs$17.0 Bil
Campbell Soup Co
CPB
VptnxcxmMmjl$13.6 Bil
Conagra Brands Inc
CAG
KpnhtydsKyryn$13.6 Bil
JM Smucker Co
SJM
XrpbXfxlk$12.0 Bil

Sponsor Center